Kissei Pharmaceutical Co (TSE:4547) Total Liabilities : 円30,863 Mil (As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

What is Kissei Pharmaceutical Co Total Liabilities?

Kissei Pharmaceutical Co's Total Liabilities for the quarter that ended in Dec. 2023 was 円30,863 Mil.

Kissei Pharmaceutical Co's quarterly Total Liabilities increased from Jun. 2023 (円28,345.00 Mil) to Sep. 2023 (円30,252.00 Mil) and increased from Sep. 2023 (円30,252.00 Mil) to Dec. 2023 (円30,863.00 Mil).

Kissei Pharmaceutical Co's annual Total Liabilities declined from Mar. 2022 (円35,909.00 Mil) to Mar. 2023 (円26,387.00 Mil) but then increased from Mar. 2023 (円26,387.00 Mil) to Mar. 2024 (円39,795.00 Mil).

Kissei Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Kissei Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kissei Pharmaceutical Co Total Liabilities Chart

Kissei Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

38,826.00

48,909.00

35,909.00

26,387.00

39,795.00

Kissei Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															26,387.00	28,345.00	30,252.00	30,863.00	39,795.00

Kissei Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Kissei Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	17663	+	(0	+	21923
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	209)
	=	39,795

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	260929	-	221134
	=	39,795

Kissei Pharmaceutical Co's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	17229	+	(0	+	13429
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	205)
	=	30,863

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	228453	-	197590
	=	30,863

Kissei Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Kissei Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kissei Pharmaceutical Co (TSE:4547) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kissei Pharmaceutical Co Ltd (TSE:4547) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

KSPHF:USA

Address

19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710

Website

http://www.kissei.co.jp

Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kissei Pharmaceutical Co (TSE:4547) Headlines

No Headlines